STEM CELL
METABOLISM &
REGENERATION
About Us
We have established a suite of cutting-edge technologies for the efficient generation of differentiated cells, including cardiomyocytes, from human induced pluripotent stem cells (hiPSCs). These hiPSC-based platforms are applied to cardiac regenerative medicine, drug discovery, and the elucidation of heart disease pathophysiology.
Members
Contact
TOHYAMA Lab. is currently recruiting new members.
If you are interested in conducting research in our laboratory, please feel free to contact us.
shugo.tohyama*fujita-hu.ac.jp
When you send e-mail to us, please change “*” to “@”.